Apyx Medical (NASDAQ:APYX) Announces Quarterly Earnings Results

Key Points

• Apyx Medical reported earnings of ($0.09) per share, meeting analysts' expectations, despite a revenue of $11.37 million that fell short of the forecast of $11.69 million.
• The company has a negative net margin of 37.11% and a negative return on equity of 143.12%, indicating financial struggles.
• Apyx Medical's stock price increased to $2.18, with a notable market cap of $82.38 million and a price-to-earnings ratio of -4.84.

Apyx Medical (NASDAQ:APYX - Get Free Report) announced its earnings results on Thursday, August 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.09), Zacks reports. The company had revenue of $11.37 million during the quarter, compared to analysts' expectations of $11.69 million. Apyx Medical had a negative net margin of 37.11% and a negative return on equity of 158.22%. Apyx Medical updated its FY 2025 guidance to EPS.

Apyx Medical Trading Down 9.8%

Shares of NASDAQ APYX traded down $0.23 during midday trading on Thursday, reaching $2.12. 146,235 shares of the stock were exchanged, compared to its average volume of 101,503. The company has a market capitalization of $80.18 million, a P/E ratio of -4.71 and a beta of 1.39. Apyx Medical has a 52-week low of $0.76 and a 52-week high of $2.73. The company has a current ratio of 4.72, a quick ratio of 3.95 and a debt-to-equity ratio of 4.61. The stock has a 50 day moving average price of $2.08 and a 200-day moving average price of $1.55.

Institutional Investors Weigh In On Apyx Medical

A hedge fund recently raised its stake in Apyx Medical stock. Nantahala Capital Management LLC lifted its position in shares of Apyx Medical Corporation (NASDAQ:APYX - Free Report) by 2.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,338,048 shares of the company's stock after buying an additional 80,000 shares during the quarter. Nantahala Capital Management LLC owned approximately 8.83% of Apyx Medical worth $7,511,000 at the end of the most recent quarter. 55.33% of the stock is currently owned by institutional investors and hedge funds.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.